Ona Therapeutics is pioneering the development of first-in-class antibody drug conjugates (ADCs) that exploit the molecular underpinnings of advanced cancer. We partner with renowned academics and clinicians to discover novel therapeutic targets from the unique biology of treatment refractory advanced cancer patients. Our approach combines privileged biology with Ona’s expertise in biologics. Together, we craft ADCs and antibody therapies, aiming to provide effective new treatments for patients with no remaining alternatives.
Company Details
- Employees
- 36
- Founded
- -
- Address
- Carrer De Baldiri Reixac, 4, Barcelona,catalonia 08028,spain
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- ona-therapeutics.com
- Keywords
- Barcelona.
- HQ
- Barcelona, Catalonia
Ona Therapeutics Questions
Ona Therapeutics's website is ona-therapeutics.com
Ona Therapeutics's LinkedIn profile is https://es.linkedin.com/company/ona-therapeutics
Ona Therapeutics has
36 employees.
View email and phone details for 36
employees at Ona Therapeutics.
Ona Therapeutics's industry is
Biotechnology Research
Ona Therapeutics's top competitors are
Oryzon Genomics Sa,
Aptadel Therapeutics,
Catalonia.health,
Splicebio,
Mimark Diagnostics,
Aelix Therapeutics,
Peptomyc,
Nuage Therapeutics,
Minoryx Therapeutics,
Deepull.
Ona Therapeutics's categories are Biotechnology Research
Ona Therapeutics's founding year is 2019
